Effects of Unprocessed and Processed Cardiopulmonary Bypass Blood Retransfused into Patients after Cardiac Surgery

Zimmermann R. , Büscher M. , Linhardt C. A survey of blood component use in a German university hospital. Transfusion 1997; 37: 1075–83.

Dietrich W. , Barankay A. , Dilthey G. , Mitto H.P. , Richter J.A. Reduction of blood utilisation during myocardial revasculatisaion. J Thorac Cardiovasc Surg 1989; 97: 213–9.

Walpoth B.H. , Schwaller J. , Hofstetter H. , Castelli D. , Nydegger U. Current problems with autologous blood supply. Infusionsther Transfusionsmed 1993; 20: 316–26.

Winton T.L. , Charrette E.J.P. , Salerno T.A. The cell saver during cardiac surgery: Does it save? Ann Thorac Surg 1982; 33: 379–81.

Haan J. , Boonstra P.W. , Monnink S.H. , Ebels T. , van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995; 59: 901–7.

Schönberger Jpam , van Oeveren W. , Bredée J.J. , Everts P.A.M. , de Haan J. Wildevuur Ch. Systemic blood activation during and after autotransfusion. Ann Thorac Surg 1994; 57: 1256–62.

Edmund L.H. Jr. . Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8: 404–10.

Butler J. , Rocker G.M. , Westaby S. Inflammatory response to cardiopulmonar bypass. Ann Thorac Surg 1993; 55: 552–9.

Neuhof H. , Soeparwata R. , Neuhof C. , Scheld H.H. Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass. Infusionsther Transfusionsmed 1993; 23.

Mori F. , Nakahara Y. , Kurata S. , Furukawa S. , Esato K. , Mohri H. Late changes in hemostatic parameters following open-heart surgery. J Cardiovasc Surg 1982; 23: 458–62.

Kirklin J.K. , Westaby S. , Blackstone E.H. , Kirklin J.W. , Chenoweth D.E. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–7.

Kestin A.S. , Valeri C.R. , Khuri S.F. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107–17.

Khuri S.F. , Wolfe J.A. , Josa M. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104: 94–107.

Moat N.E. , Shore D.F. , Evans T.W. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993; 7: 563–73.

Walpoth B.H. , Eggensperger N. , Walpoth-Aslan B.N. Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS). Int J Artif Organs 1997; 20: 234–9.

Gillinov A.M. , Redmond J.M. , Wnkelstein J.A. Complement and neutrophil activation during cardiopulmonary by-pass: A study in the complement-deficient dog. Ann Thorac Surg 1994; 57: 345–52.

Nagamine S. , Tabayashi K. , Haneda K. , Mohri H. A clinical study of respiratory complication after cardiopulmonary bypass, with special reference to complement activation, WBC and granulocyte elastase. Nippon Geka Gakkai Zasshi 1994; 95: 348–53.

Walpoth B.H. , Amport T. , Schmid R. Hemofiltration during cardiopulmonary bypass: Quality assessment of hemoconcentrated blood. Thorac Cardiovasc Surg 1994; 42: 162–9.

Steinberg J.B. , Kapelanski D.P. , Olson J.D. , Weiler J.M. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008–15.